Nucleic Acid, Nucleoside, or Nucleotide – Page 14

Moderna and Merck’s Cancer Vaccine Shows Promising Results in Combination with Keytruda

1 year ago talkbio0Tagged ASCO, Beginning, Cancer Vaccines, Keytruda, melanoma, Merck, Moderna, pilot program, RNA, Messenger, United States Food and Drug Administration

Moderna, Merck, Cancer Vaccine, Keytruda, Melanoma, mRNA Technology, ASCO, FDA, Rare Disease, START Pilot Program

FDA Approves Moderna’s RSV Vaccine, Marking Its Second Commercial Product

1 year ago talkbio0Tagged Approved, COVID19 (disease), Moderna, mRESVIA, Respiratory syncytial virus, RNA, Messenger, Spikevax, United States Food and Drug Administration, Vaccines

Moderna, RSV Vaccine, FDA Approval, mRNA Technology, Respiratory Syncytial Virus, COVID-19, Spikevax, mRESVIA

Intellia Therapeutics Advances in Hereditary Angioedema Treatment with Durable One-Dose CRISPR Gene Editing Therapy

1 year ago talkbio0Tagged Angioedemas, Hereditary, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, Intellia, Long-term, single-dose

Intellia Therapeutics, Hereditary Angioedema (HAE), CRISPR Gene Editing, NTLA-2002, Single-Dose Treatment, Long-Term Data, Clinical Trials

Bionova Scientific Expands into Plasmid DNA Services for Cell and Gene Therapy Developers

1 year ago talkbio0Tagged Asahi Kasei, Biological Factors, Bionova, CDMO, Cells, DNA, Facility (object), gene therapy, Plasmids, Science, Texas

Bionova Scientific, Plasmid DNA, Cell and Gene Therapy, CDMO, Asahi Kasei Group, Biopharmaceuticals, Biologics, Texas Facility

Intellia Therapeutics Reports Promising Long-Term Data for Single-Dose HAE Therapy

1 year ago talkbio0Tagged Angioedemas, Hereditary, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, Intellia, Long-term, NTLA-2002, single-dose

Intellia Therapeutics, NTLA-2002, Hereditary Angioedema (HAE), CRISPR Gene Editing, Single-Dose Treatment, Long-Term Data

Lilly Strengthens Neuro Pipeline with $45M Deal for QurAlis’ Preclinical ALS and Dementia Treatment

1 year ago talkbio0Tagged ALS, Amyotrophic Lateral Sclerosis, Eli Lilly, neuro pipeline, Neurodegenerative Disorders, Oligonucleotides, preclinical treatment, Presenile dementia, QRL-204, QurAlis, splice-switching antisense, UNC13A gene

Lilly, QurAlis, ALS, dementia, neurodegenerative diseases, UNC13A, splice-switching antisense oligonucleotide, QRL-204, neuro pipeline, preclinical treatment

Early Detection and Personalized Treatment of Colorectal Cancer: The Promise of Whole Genome Sequencing-Based Circulating Tumor DNA Tracking” ###

1 year ago talkbio0Tagged Adjuvant Therapy, Circulating, Circulating Tumor DNA, Colorectal Carcinoma, Detection, Liquid Biopsy, Molecular residual disease, MRD, Personalized Treatment, Whole Genome Sequencing

Circulating tumor DNA (ctDNA), Whole genome sequencing (WGS), Colorectal cancer, Early detection, Personalized treatment, Adjuvant therapy, Molecular residual disease (MRD), Liquid biopsies